Clinical Trials Logo

C-peptide clinical trials

View clinical trials related to C-peptide.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04997460 Recruiting - Hypoglycemia Clinical Trials

Diabetes Type One in Pregnancy and Continuos Glucose Monitoring

DIP1/CRO
Start date: January 11, 2021
Phase:
Study type: Observational

Type I diabetes mellitus (T1DM) affects about 0.1-0.2% of all pregnancies. T1DM in pregnancy increases the risk of maternal and neonatal complications. Continuous glucose monitoring systems (CGM) provide a continuous display of measured glucose. Studies have shown improved pregnancy outcomes for patients with T1DM using CGM when compared to capillary blood glucose measurements. This prospective observational study analyses impact of glycemic variability on development of large-for-gestational-age neonates and effects of hypoglycemia during pregnancy on pregnancy outcomes. Furthermore, overall glycemic regulation, different insulin metrics and C-peptide concentration during pregnancy will also be assesed.

NCT ID: NCT04474535 Recruiting - Type 1 Diabetes Clinical Trials

C-peptide Correlation With Microvascular Complications in T1DM

Start date: March 3, 2020
Phase:
Study type: Observational

The purpose of this study is to investigate the presence of residual insulin secretion in patients with DM1 and its correlation with the possible protection against early microvascular and macrovascular complications, emphasizing on the functionality of the myocardium.